Health and Safety
Executive / Commission
Nuclear
LLC reports
This report is issued as part of the Health and Safety Executive's commitment to make information about inspection and regulatory activities relating to the above site available to the public. It is for distribution to members of the GE Healthcare Ltd Maynard Centre Local Liaison Committee (LLC) and covers activities associated with the regulation of safety at the site. These reports are distributed quarterly and are available also from the Internet at http://www.hse.gov.uk/nuclear/index.htm. Site Inspectors of HM Nuclear Installations Inspectorate (part of the Health and Safety Executive’s Nuclear Directorate) attend LLC meetings and will be happy to respond to any questions raised there by members. Any other person wishing to inquire about matters covered by this report should contact the HSE’s, Nuclear Directorate on 0151-951-3484/3290.
Nuclear Directorate
Health and Safety Executive
Redgrave Court
Merton Road
Bootle
Merseyside
L20 7HS
NII inspections were made on 6–8 December 2006. (Inspections are also made at GE Healthcare Ltd’s nuclear licensed sites at Amersham (the Grove Centre) and Harwell. Where these are relevant to the Maynard Centre they are included below. For instance, the sites have many arrangements in common for compliance with the conditions attached to their site licences.)
[back to top]Inspections are undertaken for the purpose of monitoring compliance with (i) the conditions attached by HSE to the nuclear site licences, and (ii) other relevant provisions of the Health and Safety at Work etc Act 1974, including the Ionising Radiations Regulations 1999. In this period routine inspections included:
Issues arising from these and previous inspections are being pursued.
[back to top]New Fire Safety Regulations : The Regulatory Reform (Fire Safety) Order has replaced the fire-certification regime for the control of general fire precautions at nuclear licensed sites. HM Fire Surveyors visited the Grove Centre, where they met representatives of all of GE Healthcare Ltd’s licensed sites, to explain the new legislation and how HSE intends to enforce it.
Carbon–14: A meeting was held with the licensee and the Environment Agency to discuss the regulators’ assessment of the licensee’s study on future options for the conditioning, treatment, storage, and disposal of wastes containing carbon–14.
As part of its regulation under the nuclear site licence NII issues formal regulatory documents, which include Consents, Approvals, Directions, and Licence Instruments. No such documents were issued in this quarter.
No other issues have arisen that have required formal regulatory action.
Licence Instruments are issued: to acknowledge receipt of specified documents, eg proposals for a new or modified plant; to stipulate whether the Inspectorate intends to examine these documents; or to agree to the start of a particular phase of construction, commissioning, modification, or decommissioning.